查看所有供应商和价格请点击:
216669-97-5生产厂家
216669-97-5价格
化源商城直购
[1]. Scott AM, et al. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res. 2003 May;9(5):1639-47.